| Bid Price | 4.00p | High Price | 4.25p |
|---|
| Ask Price | 4.50p | Low Price | 4.00p |
|---|
| Open Price | 4.25p | Spread | 11.11% |
|---|
| Prev Close | 4.25p | Volume | 40,815 |
|---|
Allergy Therapeutics PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Oct 11, 2024 | 4.25 | 4.25 | 4.00 | 4.25 | 40,815 |
| Oct 10, 2024 | 4.25 | 4.50 | 4.11 | 4.25 | 107,665 |
| Oct 9, 2024 | 4.25 | 4.39 | 4.39 | 4.25 | 1,869 |
| Oct 8, 2024 | 4.50 | 5.00 | 4.00 | 4.50 | 79,459 |
| Oct 7, 2024 | 4.50 | 5.00 | 4.00 | 4.85 | 190,764 |
Allergy Therapeutics PLC Information
| Name | Allergy Therapeutics PLC | Index | |
|---|
| ISIN | GB00B02LCQ05 | Epic | AGY |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 150,000 | Trading Status | Closed |
|---|
| Shares in Issue | 4.77 bn | Prev Close | 4.25p |
|---|
| PE Ratio | 49.50495 | Market Cap | £202.57 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.354907 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 1.398742 | Quick Ratio | 0.928142 |
|---|
Allergy Therapeutics PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 13/12/23 | TIN | Manuel Llobet | RES | 1,676,200 @ £0.00 | £0.00 |
| 11/11/21 | BUY | Peter Jensen | RES | 30,000 @ £0.36 | £10,800.00 |
| 20/11/20 | BUY | Peter Jensen | RES | 100,000 @ £0.14 | £14,000.00 |
| 15/10/20 | EXR | Manuel Llobet | RES | 2,577,923 @ £0.00 | £0.00 |
| 15/10/20 | SEXR | Manuel Llobet | RES | 2,577,923 @ £0.15 | £386,688.00 |
| 24/10/18 | BUY | Peter Jensen | RES | 20,000 @ £0.18 | £3,600.00 |
| 24/10/18 | BUY | Manuel Llobet | RES | 50,000 @ £0.18 | £8,750.00 |
| 24/10/18 | BUY | Nicolas Wykeman | RES | 150,000 @ £0.18 | £26,250.00 |
| 16/03/18 | BUY | Babatunde Otulana | NED | 25,000 @ $0.39 | $9,700.00 |
| 12/10/17 | BUY | Babatunde Otulana | NED | 25,000 @ $0.51 | $12,665.00 |
Allergy Therapeutics PLC News
